Circulation
NOVEMBER 11, 2024
Introduction:Enhanced External Counterpulsation (EECP) is a noninvasive outpatient therapy designed to improve arterial health, cardiac efficiency, and coronary collateral formation by applying sequential external pressure aligned with the patient’s cardiac cycle.
Journal of the American Heart Association
FEBRUARY 29, 2024
Journal of the American Heart Association, Ahead of Print. BackgroundAnnual heart transplant (HT) volumes have increased, as have post‐HT outpatient care needs. Older patients and those with cardiac primary diagnoses had the highest risk of death.
DAIC
MARCH 13, 2024
The primary endpoint is a hierarchical composite assessment consisting of all-cause death, the cardiac death equivalents of heart transplant and left ventricular assist device (LVAD) implantation, heart failure hospitalizations, worsening heart failure events treated as an outpatient, and change in quality-of-life, with a follow-up duration ranging (..)
DAIC
MARCH 29, 2024
The primary effectiveness endpoint was a composite of death, heart transplant/left ventricular assist device (LVAD) implantation, HF hospitalization, outpatient HF worsening, and quality of life.
DAIC
APRIL 6, 2024
The results showed no significant difference between groups in terms of the trial’s primary endpoint, a hierarchical composite ranking of death from any cause; heart transplant or left ventricular assist device; heart failure hospitalizations; worsening of outpatient heart failure events; and change in quality of life, as measured using the Kansas (..)
DAIC
APRIL 6, 2024
The results showed no significant difference between groups in terms of the trial’s primary endpoint, a hierarchical composite ranking of death from any cause; heart transplant or left ventricular assist device; heart failure hospitalizations; worsening of outpatient heart failure events; and change in quality of life, as measured using the Kansas (..)
Expert insights. Personalized for you.
75 
Let's personalize your content